These tumors have traditionally been identified through immunohistochemical studies [10, 11], and, more recently, through the use of the Brachyury gene as a novel diagnostic marker that distinguishes chordomas from similar lesions, such as myoepitheliomas and chondrosarcomas [9, 12]. The gene discussed is TBX1; the disease is chondrosarcoma.